Veterans’ use of anti-anxiety drugs

Use of a class of anti-anxiety drugs fell during the past decade among veterans with posttraumatic stress disorder, a large U.S. study shows.

The study, which looked at data from more than 498,000 patients in the Veterans Affairs health care system between 1999 and 2009, found decreases in the frequency, duration and doses of benzodiazepines given to veterans with PTSD.

Treating veterans with PTSD will become even more important in coming years, the team notes, due to recent and ongoing U.S. military conflicts. The number of veterans with PTSD treated in the Veterans Affairs health care system rose nearly 200 percent between 1999 and 2009.

Article at: Journal of Clinical Psychiatry, online November 29, 2011 (subscription)